Venture startup

Who invested in Exegenesis Bio

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2021, from 1 source

Latest round
VentureFeb 2021
Investors
4
See who backed them

The rounds

  1. Feb 2021
    VentureAmount undisclosed

    Source recorded

Everyone who backed them

Temasek HoldingsVC firm1round
Legend CapitalVC firm1round
Hill House CapitalFamily office1round
K2VCVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Exegenesis Bio

Who invested in Exegenesis Bio?

Exegenesis Bio's investors include Temasek Holdings, Legend Capital, Hill House Capital and K2VC.

How much has Exegenesis Bio raised?

Exegenesis Bio has raised 1 round since 2021, none with a disclosed amount.

When did Exegenesis Bio last raise?

Exegenesis Bio's most recent round was a Venture in Feb 2021.

Who backed Exegenesis Bio first?

Exegenesis Bio's first round on record, in Feb 2021, was backed by Temasek Holdings, Legend Capital and Hill House Capital and 1 others.

What stage is Exegenesis Bio at?

Exegenesis Bio's latest named round is a Venture, in Feb 2021.

Companies like Exegenesis Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.